Trials / Completed
CompletedNCT00188604
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
A Randomized Phase II Placebo-controlled Double Blind Study of Using Selenium in the Treatment of Secondary Lymphedema in Breast Cancer Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study to assess the effectiveness of selenium compared to placebo in reducing the lymphedema in-patients with breast cancer. Secondary objectives are to assess the impact of selenium on patient's quality of life and to assess the incidence of adverse effects of selenium therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sodium selenite |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2005-09-16
- Last updated
- 2010-08-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00188604. Inclusion in this directory is not an endorsement.